November 6, 2013
The National Center for Advancing Translational Sciences (NCATS) is accepting applications through January 10, 2014, for the National Institutes of Health's Bridging Interventional Development Gaps (BrIDGs) program, part of the Common Fund. BrIDGs, which is administered by NCATS, enables successful applicants to access critical resources needed for the development of new therapeutic agents. Those selected can work with NIH contractors, who conduct pre-clinical research at no cost to the investigator. Studies can include synthesis, formulation, pharmacokinetics and toxicology to support research-led Investigational New Drug (IND) applications to the Food and Drug Administration. BrIDGs support is available to academic and nonprofit institutions, small businesses eligible for the Small Business Innovation Research program, and federal government agencies. Applications must be submitted online through proposalCENTRAL, and all potential applicants must participate in a pre-application tele
See more information on this news item.